8-K 1 a04-4939_18k.htm 8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported): April 28, 2004

 

IOMED, Inc.

(Exact name of registrant as specified in its charter)

 

Utah

 

1-14059

 

87-0441272

(State or other jurisdiction of
Incorporation or organization)

 

(Commission
File Number)

 

(I.R.S. Employer
Identification No.)

 

 

 

 

 

2441 South 3850 West, Salt Lake City, Utah

84120

(Address of principal executive offices)

(Zip Code)

 

 

(801) 975-1191

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

 

 

Item 7.                       Financial Statements, Pro Forma Financial Information and Exhibits

 

(c) Exhibits.

 

The following exhibits are filed with this Current Report on Form 8-K:

 

Exhibit
Number

 

Description

99.1*

 

Press Release Dated April 27, 2004.

 

* This information shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, and shall not be deemed incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Exchange Act of 1934 or the Securities Act of 1933, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

 

Item 12.  Results of Operations and Financial Condition

 

The information contained in this Item 12 and the exhibit hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, and shall not be deemed incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Exchange Act of 1934 or the Securities Act of 1933, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

 

On April 27, 2004, the Company issued a press release announcing financial results for the third quarter ended March 31, 2004.  The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

2

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

DATED:

 April 28, 2004

Iomed, Inc.

 

 

 

By:

/s/ Robert J. Lollini

 

 

 

Robert J. Lollini

 

 

President and Chief Executive Officer

 

3